| Nevro is a medical device company that has developed and commercialized the Senza® spinal cord stimulation, a neuromodulation platform for the treatment of chronic pain. The Senza system is approved to create electrical impulses from two Hz to 10,000 Hz, including Co.'s proprietary HF10 therapy, which allows for pain relief without paresthesia. Senza is consisted of leads, a trial stimulator, an implantable pulse generator (IPG), surgical tools, a clinician laptop programmer, a patient remote control and a mobile charger. These components enable physicians to implant the leads and the IPG, and patients to operate the system. We show 22 historical shares outstanding datapoints in our NVRO shares outstanding history coverage, used to compute NVRO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NVRO market cap history over the course of time is important for investors
interested in comparing NVRO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NVRO versus a peer is one thing; comparing
NVRO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NVRO can fluctuate over the course of history.
With this page we aim to empower investors researching NVRO by allowing them to research the NVRO market cap history.